Status:

COMPLETED

Islet Transplantation for Patients With Type 1 Diabetes

Lead Sponsor:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Diabetes Mellitus, Type 1

Eligibility:

All Genders

18-65 years

Phase:

PHASE1

Brief Summary

This protocol will test whether Type 1 diabetes (T1DM) can be reversed in patients with stable renal allografts by islet transplantation.

Detailed Description

We will test whether pancreatic islets isolated from cadaveric human donor pancreata can be transplanted into the portal vein of patients with T1DM who have stable renal allografts to achieve insulin ...

Eligibility Criteria

Inclusion

  • Patients with type 1 diabetes with stable renal allografts

Exclusion

    Key Trial Info

    Start Date :

    August 1 2003

    Trial Type :

    INTERVENTIONAL

    End Date :

    December 1 2004

    Estimated Enrollment :

    10 Patients enrolled

    Trial Details

    Trial ID

    NCT00073281

    Start Date

    August 1 2003

    End Date

    December 1 2004

    Last Update

    January 15 2010

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Columbia Presbyterian Medical Center

    New York, New York, United States, 10032